Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ HealthStream Inc. (HSTM) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Health Information Services
$24.23
-0.48 (-1.94%)Did HSTM Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if HealthStream is one of their latest high-conviction picks.
Based on our analysis of 5 Wall Street analysts, HSTM has a neutral consensus with a median price target of $34.00 (ranging from $28.00 to $40.00). The overall analyst rating is N/A (N/A/10). Currently trading at $24.23, the median forecast implies a 40.3% upside. This outlook is supported by 2 Buy, 3 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Richard Close at Canaccord Genuity, suggesting a 15.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for HSTM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 7, 2025 | Canaccord Genuity | Richard Close | Hold | Maintains | $28.00 |
| May 15, 2025 | Canaccord Genuity | Richard Close | Hold | Maintains | $29.00 |
| Feb 26, 2025 | Canaccord Genuity | Richard Close | Hold | Maintains | $30.00 |
| Feb 6, 2025 | JMP Securities | Constantine Davides | Market Perform | Reiterates | $N/A |
| Oct 23, 2024 | Barclays | Overweight | Maintains | $34.00 | |
| Oct 23, 2024 | Canaccord Genuity | Richard Close | Hold | Maintains | $29.00 |
| Jul 24, 2024 | Canaccord Genuity | Richard Close | Hold | Maintains | $28.00 |
| Dec 6, 2023 | JMP Securities | Constantine Davides | Market Perform | Initiates | $N/A |
| Feb 22, 2023 | Canaccord Genuity | Richard Close | Hold | Maintains | $26.00 |
| Apr 28, 2021 | Canaccord Genuity | Richard Close | Hold | Maintains | $24.00 |
| Oct 28, 2020 | Canaccord Genuity | Hold | Maintains | $20.00 | |
| Dec 20, 2019 | Raymond James | Market Perform | Initiates | $N/A | |
| Jul 11, 2018 | Barrington Research | Market Perform | Downgrade | $N/A | |
| Jun 14, 2018 | Baird | Neutral | Downgrade | $N/A | |
| Oct 25, 2017 | Baird | Matthew Gillmor | Outperform | Maintains | $28.00 |
| Oct 25, 2017 | Needham | Hold | Downgrade | $N/A | |
| Jul 26, 2017 | First Analysis | Equal-Weight | Upgrade | $N/A | |
| Jan 23, 2017 | First Analysis | Frank Sparacino | Underweight | Downgrade | $18.00 |
| Dec 2, 2016 | Baird | Outperform | Upgrade | $N/A | |
| Nov 4, 2016 | Craig-Hallum | Hold | Downgrade | $N/A |
The following stocks are similar to HealthStream based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
HealthStream Inc. has a market capitalization of $719.75M with a P/E ratio of 35.7x. The company generates $298.59M in trailing twelve-month revenue with a 6.9% profit margin.
Revenue growth is +4.6% quarter-over-quarter, while maintaining an operating margin of +9.9% and return on equity of +5.9%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides workforce solutions for the healthcare industry.
HealthStream generates revenue by offering cloud-based training and development platforms, credentialing services, and management tools tailored for healthcare professionals. Their solutions facilitate compliance with regulatory standards and enhance workforce performance, thereby targeting hospitals, healthcare systems, and educational institutions.
The company emphasizes improving patient outcomes by ensuring healthcare staff are well-trained and competent. HealthStream operates within a niche market, focusing on operational efficiency and regulatory compliance in the healthcare sector, which is crucial in a constantly evolving landscape.
Healthcare
Health Information Services
1,083
Mr. Robert A. Frist Jr.
United States
2000
HealthStream's Board has authorized a $10 million share repurchase program for its common stock, allowing for open market purchases and Rule 10b5-1 plan transactions.
HealthStream's $10 million share repurchase program signals confidence in its financial health and aims to enhance shareholder value, potentially driving stock price appreciation.
HealthStream, Inc. will hold its Q3 2025 earnings call on November 4, 2025, at 9:00 AM EST, featuring key executives including CEO Robert Frist and CFO Scott Roberts.
HealthStream's Q3 earnings call indicates upcoming insights into financial performance and strategic direction, crucial for assessing the company's growth and investment potential.
HealthStream, Inc. (HSTM) reported Q3 2025 revenues of $76.5 million, a 4.6% increase from Q3 2024. Operating income rose 16.5% to $7.6 million, marking a record quarterly revenue.
HealthStream's record revenue and increased operating income indicate strong growth and profitability, which may boost investor confidence and positively impact stock performance.
HealthStream (HSTM) reported quarterly earnings of $0.20 per share, surpassing the Zacks Consensus Estimate of $0.17, compared to $0.19 per share in the same quarter last year.
HealthStream's earnings beat expectations, indicating strong performance and potential growth, which may boost investor confidence and positively impact stock prices.
HealthStream, Inc. (Nasdaq: HSTM) will release its Q3 2025 financial results on November 3, 2025, and host a conference call on November 4, 2025, to discuss the results.
HealthStream's upcoming financial results announcement may influence stock performance and investor sentiment, highlighting company growth and potential market trends in healthcare technology.
HealthStream (Nasdaq: HSTM) has acquired Virsys12, enhancing its provider data management and credentialing solutions for payers and health plans.
HealthStream's acquisition of Virsys12 enhances its capabilities in provider data management, potentially increasing market share and revenue in the healthcare technology sector, which is appealing for investors.
Based on our analysis of 5 Wall Street analysts, HealthStream Inc. (HSTM) has a median price target of $34.00. The highest price target is $40.00 and the lowest is $28.00.
According to current analyst ratings, HSTM has 2 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $24.23. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict HSTM stock could reach $34.00 in the next 12 months. This represents a 40.3% increase from the current price of $24.23. Please note that this is a projection by Wall Street analysts and not a guarantee.
HealthStream generates revenue by offering cloud-based training and development platforms, credentialing services, and management tools tailored for healthcare professionals. Their solutions facilitate compliance with regulatory standards and enhance workforce performance, thereby targeting hospitals, healthcare systems, and educational institutions.
The highest price target for HSTM is $40.00 from at , which represents a 65.1% increase from the current price of $24.23.
The lowest price target for HSTM is $28.00 from Richard Close at Canaccord Genuity, which represents a 15.6% increase from the current price of $24.23.
The overall analyst consensus for HSTM is neutral. Out of 5 Wall Street analysts, 2 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $34.00.
Stock price projections, including those for HealthStream Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.